DGX vs HSIC · P/E 22, rev $5.94B vs P/E 24, rev $6.83B
Quest Diagnostics Incorporated (DGX) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the DGX and HSIC stock pages for the full models.
Not investment advice.